The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep ...

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...

Clinical research by Zepbound's manufacturer Eli Lilley found that the drug's active ingredient tirzepatide reduces sleep apnea by about 60%.

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Key Takeaways Eli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with ...

If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved ...

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

“Zepbound promotes weight loss and has been shown to reduce apnea events,” Troxel noted. “For obese individuals with moderate to severe sleep apnea, this new treatment option may offer an ...

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ...

"Zepbound promotes weight loss and has been shown to reduce apnea events." About 30 million people suffer from sleep apnea in the U.S., Troxel told Fox News Digital. While the most common treatmen ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.